ID   S100B_RAT               Reviewed;          92 AA.
AC   P04631;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   24-JUL-2024, entry version 203.
DE   RecName: Full=Protein S100-B;
DE   AltName: Full=S-100 protein beta chain;
DE   AltName: Full=S-100 protein subunit beta;
DE   AltName: Full=S100 calcium-binding protein B;
GN   Name=S100b {ECO:0000303|PubMed:19910580, ECO:0000312|RGD:3615};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=6093041; DOI=10.1093/nar/12.19.7455;
RA   Kuwano R., Usui H., Maeda T., Fukui T., Yamanari N., Ohtsuka E.,
RA   Ikehara M., Takahashi Y.;
RT   "Molecular cloning and the complete nucleotide sequence of cDNA to mRNA for
RT   S-100 protein of rat brain.";
RL   Nucleic Acids Res. 12:7455-7465(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Kuwano R., Usui H., Maeda T., Araki K., Kurihara T., Yamakuni T.,
RA   Ohtsuka E., Ikehara M., Takahashi Y.;
RT   "Molecular cloning and nucleotide sequences of cDNA and genomic DNA for
RT   alpha and beta subunits of S100 protein.";
RL   Taniguchi Symp. Brain Sci. 19:243-255(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RX   PubMed=1653388; DOI=10.1016/0169-328x(91)90061-2;
RA   Maeda T., Usui H., Araki K., Kuwano R., Takahashi Y., Suzuki Y.;
RT   "Structure and expression of rat S-100 beta subunit gene.";
RL   Brain Res. Mol. Brain Res. 10:193-202(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 6-92.
RX   PubMed=3818655; DOI=10.1016/s0021-9258(18)61388-2;
RA   Dunn R., Landry C., O'Hanlon D., Dunn J., Allore R., Brown I., Marks A.;
RT   "Reduction in S100 protein beta subunit mRNA in C6 rat glioma cells
RT   following treatment with anti-microtubular drugs.";
RL   J. Biol. Chem. 262:3562-3566(1987).
RN   [6]
RP   PROTEIN SEQUENCE OF 7-21 AND 35-56, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain, and Spinal cord;
RA   Lubec G., Afjehi-Sadat L., Kang S.U.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [7]
RP   INTERACTION WITH CACYBP.
RX   PubMed=12042313; DOI=10.1074/jbc.m203602200;
RA   Filipek A., Jastrzebska B., Nowotny M., Kuznicki J.;
RT   "CacyBP/SIP, a calcyclin and Siah-1-interacting protein, binds EF-hand
RT   proteins of the S100 family.";
RL   J. Biol. Chem. 277:28848-28852(2002).
RN   [8]
RP   FUNCTION, INTERACTION WITH AGER, AND INDUCTION.
RX   PubMed=19910580; DOI=10.1161/circresaha.109.195834;
RA   Tsoporis J.N., Izhar S., Leong-Poi H., Desjardins J.F., Huttunen H.J.,
RA   Parker T.G.;
RT   "S100B interaction with the receptor for advanced glycation end products
RT   (RAGE): a novel receptor-mediated mechanism for myocyte apoptosis
RT   postinfarction.";
RL   Circ. Res. 106:93-101(2010).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH ATAD3A.
RX   PubMed=20351179; DOI=10.1128/mcb.01468-09;
RA   Gilquin B., Cannon B.R., Hubstenberger A., Moulouel B., Falk E., Merle N.,
RA   Assard N., Kieffer S., Rousseau D., Wilder P.T., Weber D.J., Baudier J.;
RT   "The calcium-dependent interaction between S100B and the mitochondrial AAA
RT   ATPase ATAD3A and the role of this complex in the cytoplasmic processing of
RT   ATAD3A.";
RL   Mol. Cell. Biol. 30:2724-2736(2010).
RN   [10]
RP   STRUCTURE BY NMR.
RX   PubMed=8794737; DOI=10.1021/bi9612226;
RA   Drohat A.C., Amburgey J.C., Abildgaard F., Starich M.R., Baldisseri D.M.,
RA   Weber D.J.;
RT   "Solution structure of rat apo-S100B(beta beta) as determined by NMR
RT   spectroscopy.";
RL   Biochemistry 35:11577-11588(1996).
RN   [11]
RP   STRUCTURE BY NMR.
RX   PubMed=9485423; DOI=10.1021/bi972635p;
RA   Drohat A.C., Baldisseri D.M., Rustandi R.R., Weber D.J.;
RT   "Solution structure of calcium-bound rat S100B(betabeta) as determined by
RT   nuclear magnetic resonance spectroscopy.";
RL   Biochemistry 37:2729-2740(1998).
RN   [12]
RP   FUNCTION, ZINC-BINDING SITES, AND MUTAGENESIS OF HIS-16; HIS-26; HIS-43;
RP   CYS-69; CYS-85; HIS-86 AND HIS-91.
RX   PubMed=14621986; DOI=10.1021/bi035334q;
RA   Wilder P.T., Baldisseri D.M., Udan R., Vallely K.M., Weber D.J.;
RT   "Location of the Zn(2+)-binding site on S100B as determined by NMR
RT   spectroscopy and site-directed mutagenesis.";
RL   Biochemistry 42:13410-13421(2003).
RN   [13]
RP   STRUCTURE BY NMR.
RX   PubMed=10211826; DOI=10.1110/ps.8.4.800;
RA   Drohat A.C., Tjandra N., Baldisseri D.M., Weber D.J.;
RT   "The use of dipolar couplings for determining the solution structure of rat
RT   apo-S100B.";
RL   Protein Sci. 8:800-809(1999).
RN   [14]
RP   STRUCTURE BY NMR IN COMPLEX WITH CAPZA1 AND CALCIUM.
RX   PubMed=12470955; DOI=10.1016/s0022-2836(02)01152-x;
RA   Inman K.G., Yang R., Rustandi R.R., Miller K.E., Baldisseri D.M.,
RA   Weber D.J.;
RT   "Solution NMR structure of S100B bound to the high-affinity target peptide
RT   TRTK-12.";
RL   J. Mol. Biol. 324:1003-1014(2002).
RN   [15] {ECO:0007744|PDB:1XYD}
RP   STRUCTURE BY NMR, AND FUNCTION.
RX   PubMed=15823027; DOI=10.1021/bi0475830;
RA   Wilder P.T., Varney K.M., Weiss M.B., Gitti R.K., Weber D.J.;
RT   "Solution structure of zinc- and calcium-bound rat S100B as determined by
RT   nuclear magnetic resonance spectroscopy.";
RL   Biochemistry 44:5690-5702(2005).
RN   [16] {ECO:0007744|PDB:2K7O}
RP   STRUCTURE BY NMR OF 2-92 IN COMPLEX WITH CALCIUM, AND FUNCTION.
RX   PubMed=18949447; DOI=10.1007/s10858-008-9282-y;
RA   Wright N.T., Inman K.G., Levine J.A., Cannon B.R., Varney K.M., Weber D.J.;
RT   "Refinement of the solution structure and dynamic properties of Ca(2+)-
RT   bound rat S100B.";
RL   J. Biomol. NMR 42:279-286(2008).
CC   -!- FUNCTION: Small zinc- and- and calcium-binding protein that is highly
CC       expressed in astrocytes and constitutes one of the most abundant
CC       soluble proteins in brain (PubMed:14621986, PubMed:15823027,
CC       PubMed:18949447, PubMed:20351179). Weakly binds calcium but binds zinc
CC       very tightly-distinct binding sites with different affinities exist for
CC       both ions on each monomer (PubMed:15823027). Physiological
CC       concentrations of potassium ion antagonize the binding of both divalent
CC       cations, especially affecting high-affinity calcium-binding sites (By
CC       similarity). Acts as a neurotrophic factor that promotes astrocytosis
CC       and axonal proliferation (By similarity). Involved in innervation of
CC       thermogenic adipose tissue by acting as an adipocyte-derived
CC       neurotrophic factor that promotes sympathetic innervation of adipose
CC       tissue (By similarity). Binds to and initiates the activation of STK38
CC       by releasing autoinhibitory intramolecular interactions within the
CC       kinase (By similarity). Interaction with AGER after myocardial
CC       infarction may play a role in myocyte apoptosis by activating ERK1/2
CC       and p53/TP53 signaling (PubMed:19910580). Could assist ATAD3A
CC       cytoplasmic processing, preventing aggregation and favoring
CC       mitochondrial localization (By similarity). May mediate calcium-
CC       dependent regulation on many physiological processes by interacting
CC       with other proteins, such as TPR-containing proteins, and modulating
CC       their activity (By similarity). {ECO:0000250|UniProtKB:P02638,
CC       ECO:0000250|UniProtKB:P04271, ECO:0000250|UniProtKB:P50114,
CC       ECO:0000269|PubMed:14621986, ECO:0000269|PubMed:15823027,
CC       ECO:0000269|PubMed:18949447, ECO:0000269|PubMed:19910580,
CC       ECO:0000269|PubMed:20351179}.
CC   -!- SUBUNIT: Dimer of either two alpha chains, or two beta chains, or one
CC       alpha and one beta chain (By similarity). The S100B dimer binds two
CC       molecules of STK38 (By similarity). Interacts with CACYBP in a calcium-
CC       dependent manner (PubMed:12042313). Interacts with ATAD3A; this
CC       interaction probably occurs in the cytosol prior to ATAD3A
CC       mitochondrial targeting (PubMed:20351179). Interacts with S100A6 (By
CC       similarity). The S100B dimer interacts with two molecules of CAPZA1
CC       (PubMed:12470955). Interacts with AGER (PubMed:19910580). Interacts
CC       with PPP5C (via TPR repeats); the interaction is calcium-dependent and
CC       modulates PPP5C activity (By similarity). Interacts with TPPP; this
CC       interaction inhibits TPPP dimerization (By similarity). Interacts with
CC       isoform CLSTN3beta of CLSTN3; interaction promotes secretion (By
CC       similarity). {ECO:0000250|UniProtKB:P02638,
CC       ECO:0000250|UniProtKB:P04271, ECO:0000250|UniProtKB:P50114,
CC       ECO:0000269|PubMed:12042313, ECO:0000269|PubMed:12470955,
CC       ECO:0000269|PubMed:19910580, ECO:0000269|PubMed:20351179}.
CC   -!- INTERACTION:
CC       P04631; Q63495: Ager; NbExp=3; IntAct=EBI-2696631, EBI-6479195;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P04271}. Nucleus
CC       {ECO:0000250|UniProtKB:P04271}. Secreted
CC       {ECO:0000250|UniProtKB:P50114}. Note=Secretion into the medium is
CC       promoted by interaction with isoform CLSTN3beta of CLSTN3.
CC       {ECO:0000250|UniProtKB:P50114}.
CC   -!- TISSUE SPECIFICITY: Although predominant among the water-soluble brain
CC       proteins, S100 is also found in a variety of other tissues.
CC       {ECO:0000269|PubMed:1653388}.
CC   -!- INDUCTION: Up-regulated in periinfarct ventricular myocardium.
CC       {ECO:0000269|PubMed:19910580}.
CC   -!- SIMILARITY: Belongs to the S-100 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X01090; CAA25567.1; -; mRNA.
DR   EMBL; M54919; AAA42096.1; -; mRNA.
DR   EMBL; S53527; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; S53522; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC087026; AAH87026.1; -; mRNA.
DR   EMBL; M15705; -; NOT_ANNOTATED_CDS; mRNA.
DR   PIR; A60046; A26557.
DR   RefSeq; NP_037323.1; NM_013191.1.
DR   RefSeq; XP_008771090.1; XM_008772868.1.
DR   RefSeq; XP_017457057.1; XM_017601568.1.
DR   PDB; 1B4C; NMR; -; A/B=1-92.
DR   PDB; 1DT7; NMR; -; A/B=1-92.
DR   PDB; 1MWN; NMR; -; A/B=1-92.
DR   PDB; 1QLK; NMR; -; A/B=1-92.
DR   PDB; 1SYM; NMR; -; A/B=1-92.
DR   PDB; 1XYD; NMR; -; A/B=1-92.
DR   PDB; 2K7O; NMR; -; A/B=2-92.
DR   PDBsum; 1B4C; -.
DR   PDBsum; 1DT7; -.
DR   PDBsum; 1MWN; -.
DR   PDBsum; 1QLK; -.
DR   PDBsum; 1SYM; -.
DR   PDBsum; 1XYD; -.
DR   PDBsum; 2K7O; -.
DR   AlphaFoldDB; P04631; -.
DR   BMRB; P04631; -.
DR   SMR; P04631; -.
DR   BioGRID; 247770; 2.
DR   IntAct; P04631; 3.
DR   STRING; 10116.ENSRNOP00000001743; -.
DR   BindingDB; P04631; -.
DR   ChEMBL; CHEMBL3763006; -.
DR   DrugCentral; P04631; -.
DR   iPTMnet; P04631; -.
DR   PhosphoSitePlus; P04631; -.
DR   SwissPalm; P04631; -.
DR   PaxDb; 10116-ENSRNOP00000001743; -.
DR   ABCD; P04631; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00055039457; ENSRNOP00055032032; ENSRNOG00055022964.
DR   Ensembl; ENSRNOT00060041565; ENSRNOP00060034444; ENSRNOG00060024014.
DR   Ensembl; ENSRNOT00065044031; ENSRNOP00065036114; ENSRNOG00065025565.
DR   GeneID; 25742; -.
DR   KEGG; rno:25742; -.
DR   UCSC; RGD:3615; rat.
DR   AGR; RGD:3615; -.
DR   CTD; 6285; -.
DR   RGD; 3615; S100b.
DR   VEuPathDB; HostDB:ENSRNOG00000001295; -.
DR   eggNOG; ENOG502S4HJ; Eukaryota.
DR   HOGENOM; CLU_138624_2_0_1; -.
DR   InParanoid; P04631; -.
DR   OrthoDB; 4606407at2759; -.
DR   PhylomeDB; P04631; -.
DR   TreeFam; TF332727; -.
DR   Reactome; R-RNO-445989; TAK1-dependent IKK and NF-kappa-B activation.
DR   Reactome; R-RNO-879415; Advanced glycosylation endproduct receptor signaling.
DR   Reactome; R-RNO-933542; TRAF6 mediated NF-kB activation.
DR   EvolutionaryTrace; P04631; -.
DR   PRO; PR:P04631; -.
DR   Proteomes; UP000002494; Chromosome 20.
DR   Bgee; ENSRNOG00000001295; Expressed in Ammon's horn and 20 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0001726; C:ruffle; ISO:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0048306; F:calcium-dependent protein binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0050786; F:RAGE receptor binding; IPI:RGD.
DR   GO; GO:0044548; F:S100 protein binding; ISO:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:RGD.
DR   GO; GO:0048156; F:tau protein binding; ISS:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:1990845; P:adaptive thermogenesis; ISS:UniProtKB.
DR   GO; GO:0048708; P:astrocyte differentiation; IEP:RGD.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0007611; P:learning or memory; ISS:UniProtKB.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IEP:RGD.
DR   GO; GO:0007613; P:memory; ISO:RGD.
DR   GO; GO:2001015; P:negative regulation of skeletal muscle cell differentiation; IMP:RGD.
DR   GO; GO:1990138; P:neuron projection extension; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0031643; P:positive regulation of myelination; IMP:RGD.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; ISO:RGD.
DR   GO; GO:0050806; P:positive regulation of synaptic transmission; IMP:RGD.
DR   GO; GO:0008360; P:regulation of cell shape; IMP:RGD.
DR   GO; GO:0048168; P:regulation of neuronal synaptic plasticity; ISO:RGD.
DR   GO; GO:0051384; P:response to glucocorticoid; IEP:RGD.
DR   GO; GO:0051597; P:response to methylmercury; IEP:RGD.
DR   GO; GO:0097490; P:sympathetic neuron projection extension; ISS:UniProtKB.
DR   CDD; cd05027; S-100B; 1.
DR   Gene3D; 1.10.238.10; EF-hand; 1.
DR   IDEAL; IID50019; -.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR028481; S100-B.
DR   InterPro; IPR001751; S100/CaBP7/8-like_CS.
DR   InterPro; IPR013787; S100_Ca-bd_sub.
DR   PANTHER; PTHR11639:SF134; PROTEIN S100-A1-RELATED; 1.
DR   PANTHER; PTHR11639; S100 CALCIUM-BINDING PROTEIN; 1.
DR   Pfam; PF00036; EF-hand_1; 1.
DR   Pfam; PF01023; S_100; 1.
DR   SMART; SM00054; EFh; 1.
DR   SMART; SM01394; S_100; 1.
DR   SUPFAM; SSF47473; EF-hand; 1.
DR   PROSITE; PS00018; EF_HAND_1; 1.
DR   PROSITE; PS50222; EF_HAND_2; 1.
DR   PROSITE; PS00303; S100_CABP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Calcium; Cell adhesion; Cytoplasm;
KW   Direct protein sequencing; Metal-binding; Nucleus; Reference proteome;
KW   Repeat; Secreted; Zinc.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P02638"
FT   CHAIN           2..92
FT                   /note="Protein S100-B"
FT                   /id="PRO_0000143969"
FT   DOMAIN          13..48
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          49..84
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         16
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000305|PubMed:14621986"
FT   BINDING         19
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /ligand_note="low affinity"
FT                   /evidence="ECO:0000269|PubMed:18949447,
FT                   ECO:0007744|PDB:2K7O"
FT   BINDING         22
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /ligand_note="low affinity"
FT                   /evidence="ECO:0000269|PubMed:18949447,
FT                   ECO:0007744|PDB:2K7O"
FT   BINDING         26
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000305|PubMed:14621986"
FT   BINDING         27
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /ligand_note="low affinity"
FT                   /evidence="ECO:0000269|PubMed:18949447,
FT                   ECO:0007744|PDB:2K7O"
FT   BINDING         32
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /ligand_note="low affinity"
FT                   /evidence="ECO:0000269|PubMed:18949447,
FT                   ECO:0007744|PDB:2K7O"
FT   BINDING         62
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:18949447, ECO:0007744|PDB:2K7O"
FT   BINDING         64
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:18949447, ECO:0007744|PDB:2K7O"
FT   BINDING         66
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:18949447, ECO:0007744|PDB:2K7O"
FT   BINDING         68
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:18949447, ECO:0007744|PDB:2K7O"
FT   BINDING         73
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:18949447, ECO:0007744|PDB:2K7O"
FT   BINDING         86
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000305|PubMed:14621986"
FT   BINDING         91
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000305|PubMed:14621986"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P02638"
FT   MUTAGEN         16
FT                   /note="H->A: Decreased zinc-binding."
FT                   /evidence="ECO:0000269|PubMed:14621986"
FT   MUTAGEN         26
FT                   /note="H->A: Decreased zinc-binding."
FT                   /evidence="ECO:0000269|PubMed:14621986"
FT   MUTAGEN         43
FT                   /note="H->A: Does not affect zinc-binding."
FT                   /evidence="ECO:0000269|PubMed:14621986"
FT   MUTAGEN         69
FT                   /note="C->A: Does not affect zinc-binding."
FT                   /evidence="ECO:0000269|PubMed:14621986"
FT   MUTAGEN         85
FT                   /note="C->A: Decreased zinc-binding."
FT                   /evidence="ECO:0000269|PubMed:14621986"
FT   MUTAGEN         86
FT                   /note="H->A: Decreased zinc-binding."
FT                   /evidence="ECO:0000269|PubMed:14621986"
FT   MUTAGEN         91
FT                   /note="H->A: Decreased zinc-binding."
FT                   /evidence="ECO:0000269|PubMed:14621986"
FT   HELIX           3..18
FT                   /evidence="ECO:0007829|PDB:1B4C"
FT   STRAND          21..23
FT                   /evidence="ECO:0007829|PDB:1SYM"
FT   STRAND          25..29
FT                   /evidence="ECO:0007829|PDB:1DT7"
FT   HELIX           30..40
FT                   /evidence="ECO:0007829|PDB:1B4C"
FT   HELIX           41..43
FT                   /evidence="ECO:0007829|PDB:1QLK"
FT   HELIX           44..47
FT                   /evidence="ECO:0007829|PDB:1B4C"
FT   HELIX           51..62
FT                   /evidence="ECO:0007829|PDB:1B4C"
FT   STRAND          66..69
FT                   /evidence="ECO:0007829|PDB:1B4C"
FT   HELIX           71..84
FT                   /evidence="ECO:0007829|PDB:1B4C"
FT   STRAND          85..87
FT                   /evidence="ECO:0007829|PDB:1B4C"
FT   TURN            88..90
FT                   /evidence="ECO:0007829|PDB:1XYD"
SQ   SEQUENCE   92 AA;  10744 MW;  43815AC212BEC7D0 CRC64;
     MSELEKAMVA LIDVFHQYSG REGDKHKLKK SELKELINNE LSHFLEEIKE QEVVDKVMET
     LDEDGDGECD FQEFMAFVSM VTTACHEFFE HE
//
